A three-compartment open pharmacokinetic model can explain variable toxicities of cobra venoms and their alpha toxins
- 1 September 1996
- Vol. 34 (9) , 1011-1026
- https://doi.org/10.1016/0041-0101(96)00055-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The ocular effects of spitting cobras: II. Evidence that cardiotoxins are responsible for the corneal opacification syndromeJournal of Toxicology: Clinical Toxicology, 1993
- Experimental treatment protocols for scorpion envenomation: A review of common therapies and an effect of kallikrein-kinin inhibitorsToxicon, 1992
- Mean Time Parameters Dealing with the Tissue Distribution of Drugs: Limitations and ExtensionsJournal of Pharmaceutical Sciences, 1989
- Mean residence time in peripheral tissue: A linear disposition parameter useful for evaluating a drug's tissue distributionJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Pharmacokinetics of 125I-labelled venom from the scorpion Androctonus amoreuxi, Aud. and Sav.Toxicon, 1980
- Turnover of junctional and extrajunctional acetylcholine receptors of the rat diaphragmNature, 1975
- Chemistry and Pharmacology of Polypeptide Toxins in Snake VenomsAnnual Review of Pharmacology, 1972
- Determination of potassium ion concentration in serum using a highly selective liquid-membrane electrodeClinica Chimica Acta; International Journal of Clinical Chemistry, 1970
- Absorption and distribution of 131I-labeled cobra venom and its purified toxinsToxicology and Applied Pharmacology, 1968
- Cobra-bitesBMJ, 1964